ebook Munafa Stock Market Course + Intraday & FNO calls  

       

532523 announcements Biocon Ltd. announcements and dividends declared BSE

Biocon Ltd. Complete list of announcements declared & dividend announcements by Biocon Ltd. 532523

Biocon Ltd. 532523 listed on BSE and deals in

Announcements and dividends declared by Biocon Ltd. 532523

Biocon shares: Active Pine may divest up to 1% equity worth Rs 638 crore via block deal
Active Pine is likely to sell up to 1.66 crore Biocon shares, worth Rs 638 crore, through a block deal at Rs 385 per share. The development comes alongside Biocon’s Brazil partnership for Pertuzumab under a 10-year programme.
Announcement as on 08 September 2026

Biocon arm gets Japan nod for cancer drug pegfilgrastim biosimilar
In a significant advancement, Biocon Biologics has gained marketing approval for its pegfilgrastim biosimilar in Japan. This vital cancer supportive care drug is designed to mitigate infection risks following chemotherapy. Developed as a rival to Neulasta,
Announcement as on 25 August 2026

Biocon shares rise 2% after USFDA approval for Yesintek single-dose prefilled autoinjector
Biocon shares rose after its US subsidiary received supplemental FDA approval for Yesintek single-dose prefilled autoinjectors in two strengths. The approval expands Biocon’s US immunology portfolio, with Yesintek used to treat conditions including plaque
Announcement as on 18 August 2026

Biocon arm gets supplemental USFDA approval for autoimmune disease drug
Biocon Ltd on Tuesday said its subsidiary has received supplemental approval from the US health regulator for Yesintek prefilled autoinjector. Yesintek is indicated for the treatment of moderate-to-severe plaque psoriasis and active psoriatic arthritis. Th
Announcement as on 18 August 2026

Biocon gets Health Canada nod for Yesintek autoinjector pen
Biocon received Health Canada approval for its Yesintek autoinjector. This new format offers patients a convenient treatment option for psoriasis. The autoinjector is also indicated for psoriatic arthritis and Crohn's disease. This approval strengthens Bio
Announcement as on 29 July 2026

Announcements by Biocon Ltd. first page | Next page |

532523 Biocon Ltd. current price & indicator signals

Moving Averages for Biocon Ltd.

  • 5Day Average: 382.2
  • 12Day Average: 390.22
  • 20Day Average: 398.71
  • 50Day Average: 416.07
  • 100Day Average: 412.74
  • 150Day Average: 399.27
  • 200Day Average: 395.22

532523 Indicators & signals

Indicator MACD (12,26,9)

389.87, 399.81, -8.5
Indicator MACD is in negative zone

Indicator ADX (14)

32.38, 15.59, 30.52
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 48
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 532523 Biocon Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
18 Fri Sep 2026 385.00 379.50 to 388.80 1.32% 0.05 times
17 Thu Sep 2026 380.00 370.45 to 381.75 1.59% 0.03 times
16 Wed Sep 2026 374.05 374.00 to 383.70 -1.82% 0.04 times
15 Tue Sep 2026 381.00 381.00 to 392.50 -2.55% 0.06 times
11 Fri Sep 2026 390.95 384.80 to 396.65 0.24% 0.05 times
10 Thu Sep 2026 390.00 388.65 to 397.50 -1.27% 0.06 times
09 Wed Sep 2026 395.00 393.10 to 403.95 0.62% 9.45 times
08 Tue Sep 2026 392.55 390.90 to 399.50 -0.24% 0.07 times
07 Mon Sep 2026 393.50 388.70 to 397.25 -0.94% 0.16 times
04 Fri Sep 2026 397.25 396.50 to 404.80 -1.18% 0.04 times
03 Thu Sep 2026 402.00 400.60 to 405.70 0.17% 0.03 times
02 Wed Sep 2026 401.30 397.85 to 402.00 0.01% 0.28 times

Videos related to: 532523 announcements Biocon Ltd. announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

532523 announcements Biocon Ltd. announcements and dividends declared BSE

 

Back to top